Prazosin for ETOH or Cocaine Craving

Summary

This double-blind placebo controlled crossover pilot trial will test the hypothesis that prazosin, an alpha-1 adrenergic receptor antagonist, reduces craving for their drug of choice in cocaine-dependent and alcohol-dependent veterans. Both the study medication period and the placebo period are each 4 weeks in duration.

Timeline

Start

2004-04

Primary completion

2009-01

Completion

2009-01

Drugs

Indications